Surgery Partners, Inc.
SGRY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $821,500 | $826,200 | $776,000 | $864,400 |
| % Growth | -0.6% | 6.5% | -10.2% | – |
| Cost of Goods Sold | $626,200 | $630,600 | $614,100 | $630,800 |
| Gross Profit | $195,300 | $195,600 | $161,900 | $233,600 |
| % Margin | 23.8% | 23.7% | 20.9% | 27% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $323,800 | $36,100 | $36,000 | $36,000 |
| SG&A Expenses | $323,800 | $36,100 | $36,000 | $36,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$234,200 | $47,800 | $64,000 | $70,500 |
| Operating Expenses | $89,600 | $83,900 | $100,000 | $106,500 |
| Operating Income | $105,700 | $111,700 | $61,900 | $127,100 |
| % Margin | 12.9% | 13.5% | 8% | 14.7% |
| Other Income/Exp. Net | -$74,900 | -$67,900 | -$62,200 | -$52,900 |
| Pre-Tax Income | $30,800 | $43,800 | -$300 | $74,200 |
| Tax Expense | $5,500 | -$1,100 | $0 | $120,800 |
| Net Income | -$22,700 | -$2,500 | -$37,700 | -$108,500 |
| % Margin | -2.8% | -0.3% | -4.9% | -12.6% |
| EPS | -0.18 | -0.02 | -0.3 | -0.86 |
| % Growth | -813.7% | 93.4% | 65.1% | – |
| EPS Diluted | -0.18 | -0.02 | -0.3 | -0.86 |
| Weighted Avg Shares Out | 126,932 | 126,980 | 126,602 | 126,209 |
| Weighted Avg Shares Out Dil | 126,932 | 126,980 | 126,602 | 126,209 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $335,100 | $67,900 | $62,200 | $52,900 |
| Depreciation & Amortization | $39,500 | $40,300 | $36,300 | $33,900 |
| EBITDA | $405,400 | $152,000 | $98,200 | $161,000 |
| % Margin | 49.3% | 18.4% | 12.7% | 18.6% |